Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFB | P00751 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 5/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.40 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 4/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 4/20 | 0.32 |
| ▸ | CYTH2 | Q99418 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9788327 | 0.87 | CFB (0.54) | CFBTAAR1ADRA2AADRA1AADRA2B | |
| SCHEMBL9788271 | 0.80 | TNIK (0.45) | CFBTAAR1ADRA2AADRA1ATNIK | |
| SCHEMBL9788287 | 0.76 | CFB (0.40) | CFBTAAR1ADRA2AADRA1AADRA2B | |
| SCHEMBL9788343 | 0.76 | TAAR1 (0.44) | CFBTAAR1ADRA2AADRA1AADRA2B | |
| SCHEMBL9788300 | 0.76 | CFB (0.40) | CFBTAAR1ADRA2AADRA1AADRA2B | |
| SCHEMBL9788345 | 0.76 | CFB (0.55) | CFBTAAR1ADRA2AADRA1AADRA2B | |
| SCHEMBL9788308 | 0.74 | CFB (0.53) | CFBTAAR1ADRA2AADRA1AADRA2B | |
| SCHEMBL9788340 | 0.74 | CFB (0.50) | CFBTAAR1ADRA2AADRA1ATNIK | |
| SCHEMBL9788290 | 0.73 | TAAR1 (0.50) | CFBTAAR1ADRA2AADRA1AADRA2B | |
| SCHEMBL9788339 | 0.72 | ADRA2A (0.36) | CFBTAAR1ADRA2AADRA1AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5066664-A | Control of intraocular bleeding and pressure | ALLERGAN, INC. (US) | 1991-11-19 | — | — | US | disclosed |